Pursuant to Regulation 30 read with Para A of Schedule III of SEBI (LODR) Regulations, 2015, Sigachi Industries has informed that, Atul Dhavle is appointed as Chief People Officer of the Company with effect from January 3, 2026. A press release and details with respect to the above appointment as required under Regulation 30 of Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/CFD-CFD-PoDI/P/CIR/2023/123 dated July 13, 2023 are provided in the Annexure to this letter.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: